Toggle sidebar
Pricing
Sign In
康惠制药筹划控制权变更,连续三年亏损,新实控方耗资超5亿元
KANGHUI PHARMACEUTICAL(SH:603139)
Hua Xia Shi Bao
·
2025-03-26 04:47